InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-33.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Jones Adrian M, Director. Officer active across 2 companies, notably T2 Biosystems, Inc.. In total, 8 reports have been recorded. Split: 2 buys · 5 sells. Total volume traded: €453.6m. Activity tracked since 24 March 2020. The latest transaction was disclosed on 13 December 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
49,807,744 sharesCommon StockSEC:0001359316-24-000015:0
157 shares@ US$13.580.0% of flowCommon StockSEC:0001628280-23-042671:0
1,145,486 shares@ US$11.732.7% of flowCommon StockSEC:0001209191-23-040514:0
8,000,000 shares@ US$11.7319.2% of flowCommon StockSEC:0001209191-23-037177:0
9,603,419 shares@ US$21.5650.0% of flowCommon StockSEC:0000895345-21-000887:0
9,603,419 shares@ US$21.5639.0% of flowCommon StockSEC:0000895345-21-000887
500 shares@ US$0.3780.78% mcap50.0% of flowCommon StockSEC:0000899243-21-031361:0
Ideal exit: 19 Dec 2020 (T+270)
500 shares@ US$0.37850.0% of flowCommon StockSEC:0000899243-21-031361
Ideal exit: 19 Dec 2020 (T+270)
8 of 8 declarations
About Jones Adrian M
Adrian M. Jones is a Board Member of T2 Biosystems, Inc. and Sterling Check Corp. As a board member, he plays a key role in overseeing operations and making strategic decisions for these companies. His experience in the biotechnology and verification services sectors enables him to contribute effectively to discussions within the board.
